Financials
- Market Capitalization 1.18 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.26
ratio cours/chiffre d'affaires
12.53
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2335 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.39 USD | -1.77% | +2.13% | +4.12% | +135.52% | 1.21 B USD | ||
| 2354 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.84 USD | -3.76% | +3.36% | -11.40% | +22.48% | 1.18 B USD | ||
| 2373 | SANA Sana Biotechnology, Inc. - Common Stock | 3.85 USD | -1.79% | -0.52% | +10.32% | +27.06% | 1.15 B USD | ||
| 2393 | SVRA Savara, Inc. - Common Stock | 5.37 USD | 0.00% | +2.29% | -2.72% | +39.48% | 1.10 B USD |